Stock CDYDA CELLMID LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Cellmid Limited Share Price Australian S.E.

Equities

CDYDA

AU0000CDYDA5

Personal Products

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 9.23M 6.12M 510M Sales 2023 9.11M 6.03M 504M Capitalization 6.22M 4.12M 344M
Net income 2022 -3M -1.99M -166M Net income 2023 -2M -1.32M -111M EV / Sales 2022 0.39 x
Net cash position 2022 1.53M 1.01M 84.45M Net cash position 2023 1.91M 1.27M 106M EV / Sales 2023 0.47 x
P/E ratio 2022
-1.32 x
P/E ratio 2023
-1.7 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 59.37%
More Fundamentals * Assessed data

Chart Cellmid Limited

Dynamic Chart

Latest news about Cellmid Limited

Anagenics Appoints CEO MT
Anagenics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Anagenics Completes Placement to Raise AU$1.3 Million MT
Anagenics Grows Fiscal H1 Revenue MT
Anagenics Acquires Face Medi Group MT
Anagenics Limited Announces Board Executive Changes CI
Anagenics Limited completed the acquisition of Face MediGroup. CI
Anagenics Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Anagenics Limited agreed to acquire Face MediGroup for AUD 1.3 million. CI
Anagenics Appoints CEO/Managing Director MT
Anagenics Limited Appoints Scott Greasley as Managing Director, Effective from 1 April 2023 CI
Anagenics Limited Announces CEO Changes CI
Anagenics Raises Funds from Institutional Entitlement Offer MT
Anagenics Raising AU$3.2 Million Via Entitlement Offer MT
Anagenics Limited Appoints Karen Matthews as Non-Executive Director CI
More news

Press releases Cellmid Limited

Anagenics : FY2022 Annual Report PU
Anagenics : Appendix 4C and Quarterly Activity Report PU
Anagenics : Appendix 4C and Quarterly Activity Report PU
Cellmid : AGM Presentation to Shareholders PU
Cellmid : Alopecia Patent allowed in Europe PU
More press releases

Managers and Directors - Cellmid Limited

Managers TitleAgeSince
Matthew Dudek DFI
 Director of Finance/CFO - 01/20/01
Dominic Burg COO
 Chief Operating Officer - 01/16/01
Scott Greasley BRD
 Director/Board Member - 08/22/08
Members of the board TitleAgeSince
Sandy Beard CHM
 Chairman 58 15/22/15
Karen Matthews CEO
 Chief Executive Officer - 14/23/14
Phillip Christopher BRD
 Director/Board Member - 05/21/05
More insiders

Company Profile

Anagenics Limited is an Australia-based health and beauty-tech company. The Company offers a range of clinically validated anti-ageing and wellness products developed in-house or sourced from premium international brands. The Company, through its wholly owned subsidiary Advangen Pty Ltd, develops, manufactures and markets anti-aging products globally, with its FGF5 inhibitor hair health and hair growth products sold worldwide. The flagship anti-aging hair care range, marketed as evolis, Advangen Jo-Ju and Lexilis brands, is sold in Japan, the United States of America and Australia. The Company’s subsidiary is BLC Cosmetics Pty Limited, which is the distributor of international and local skin care and wellbeing brands.
Sector
Personal Products
Calendar
28/08/2024 - Q4 2024 Earnings Release (Projected)
More about the company

Sector Other Personal Products

1st Jan change Capi.
PROCTER & GAMBLE COMPANY Stock Procter & Gamble Company
+12.22% 388B
UNILEVER PLC Stock Unilever PLC
+10.21% 132B
HINDUSTAN UNILEVER LIMITED Stock Hindustan Unilever Limited
-15.32% 62.43B
ESTEE LAUDER Stock Estee Lauder
-11.06% 47.67B
KENVUE INC. Stock Kenvue Inc.
-11.38% 36.76B
BEIERSDORF Stock Beiersdorf
+6.08% 34.51B
ESSITY AB Stock Essity AB
+10.80% 17.86B
GODREJ CONSUMER PRODUCTS LIMITED Stock Godrej Consumer Products Limited
+10.52% 15.35B
DABUR INDIA LIMITED Stock Dabur India Limited
-4.74% 11.3B
Other Personal Products
  1. Stock Market
  2. Equities
  3. AN1 Stock
  4. CDYDA Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW